The fourth and final full day of the 2017 Aging in America Conference kicked off at 7:00 AM with a yoga session in Plaza AB led by Oklahoma City Parks and Recreation Senior Activity Center Director Douglas Paulsen. At 8:00 AM the 14th Annual What’s Next Boomer Business Summit got underway in the Regency Ballroom and nearby meeting rooms.
The third day of the 2017 Aging in America conference continued the unique learning and community-building experience, and our attendees and faculty are not slowing down.
From the morning exercise and morning buzz with the Students and Emerging Professionals (STEP) Group to the Exhibit Hall Grand Opening Reception and Chicago dine-around, the 2017 Aging in America Conference was fully underway on Tuesday with nearly 2,500 participants.
Every year, this conference heralds an extraordinary creation and sustaining of community and commitment. Between individuals who are just meeting for the first time, or who have worked together for decades, thousands of moments of learning, sharing, renewal and discovery take place.
Welcome to Aging in America 2017! A record-breaking 1,650 people came through the conference registration area (and patiently waited at points in some long lines). Attendees didn't lose any time fanning out to the 90+ workshops, symposia and other programs. From the National Forum on Family Caregiving to the evening peer groups, a beautifully diverse community of professionals began a week-long journey of learning, sharing and connecting.
As readers peruse this issue of Aging Today, Donald Trump is more than a third through the first 100 days of his presidency, a key milestone Trump has made more significant through his boasts of what he will do. It’s a “shock and awe” kind of legislative first year, as John Cutler notes in his In Focus story elsewhere in this issue.
When there is a new Administration in office it is always a good time to address pressing issues. And this occasion also coincides with a new Congress intent on making good on their promises.
These are times of great ferment in relation to prescription drugs, especially as they relate to older patients. Controversy and change are brewing in the areas of medication research, approval, promotion, pricing and reimbursement. From the perspective of care for elders, many proposed changes are worrisome, and few are encouraging.
Drug Research and Development
By Nancy J. Altman